Crossmark

Influence of inhalation device, active substance, and drug formulation on the compliance of patients with obstructive pulmonary diseases. A physicians’ perspective

Crossref DOI link: https://doi.org/10.1016/j.pulmoe.2020.11.008

Published Online: 2025-03-10

Published Print: 2023-01-30

Update policy: https://doi.org/10.1080/tandf_crossmark_01

Authors

Theodorakis, S.G.

Kolios, G.

Tzilas, V.

Bouros, D.
License Information

Version of Record valid from 2023-01-30
More Information

Peer Review Statement: The publishing and review policy for this title is described in its Aims & Scope.

Aim & Scope: http://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=tpul20

Publication History

Received: 2020-07-07

Accepted: 2020-11-23

Published: 2025-03-10

Document is current

Any future updates will be listed below